ivWatch evaluation prevented 122 cases of infiltration and extravasation
Abstract:
Occasionally, the administration of intravenous (IV) therapies can go wrong. Infiltration or extravasation is a complication when a drug or IV therapy leaks into the tissues surrounding the vascular access device. Extravasation can cause serious and often life-changing injuries. Extravasation is often associated with systemic anti-cancer therapy but non-chemotherapy drugs have been reported as having a greater risk of serious complications. This study outlines the first UK Infusion unit evaluation of the ivWatch infusion monitoring device which was undertaken from August 2023 to January 2024. Out of 2254 infusions monitored with ivWatch, the device prevented 122 cases of infiltration and extravasation from causing any harm to the patient, corresponding to a 5.4% ‘check IV’ notification rate.
Reference:
Barton A. Extravasation and infiltration: under-recognised complications of intravenous therapy. Br J Nurs. 2024 Apr 4;33(7):S18-S26. doi: 10.12968/bjon.2024.33.7.S18. PMID: 38578942.